2 Undervalued Stocks We Like
Our analysts are excited about these names.
Today we're looking at two overlooked narrow-moat stocks.
DuPont (DD) is undervalued as investors are overly concerned about the company's long-term earnings power, elevated debt levels, and future liabilities related to the company's former PFAS operations. However, we see a bright long-term future for the company. While DuPont's transportation business has seen its profits sharply decline in the first half of 2020, we expect it will fully rebound as global auto builds recover. Longer term, we see growth coming from greater electric vehicle and hybrid adoption, as DuPont generates around 50% more revenue per vehicle on an EV or hybrid than for an internal combustion engine vehicle. We also see long-term growth in the electronics business from the adoption of 5G and in the safety and construction business from U.S. housing starts growth. Although DuPont carries elevated leverage as a result of the DowDuPont spin-off, the company should quickly improve its balance sheet health following the sale of its nutrition and biosciences business. The transaction features a $7.3 billion dividend payment to DuPont, which it will mostly use to reduce debt. Finally, we view PFAS liabilities as a minor concern for DuPont.
Morningstar does not own (actual or beneficial) shares in any of the securities mentioned above. Find out about Morningstar’s editorial policies.
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.
We’d like to share more about how we work and what drives our day-to-day business.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.
How we use your information depends on the product and service that you use and your relationship with us. We may use it to:
To learn more about how we handle and protect your data, visit our privacy center.
Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.
To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.
Read our editorial policy to learn more about our process.